Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Study Design:
Retrospective
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must be continuously enrolled in a health plan during the pre-index period;
Patients must have at least one inpatient, or one physician office visit, emergency room visit with a diagnosis of AF (ICD-9-CM diagnosis code: 427.31in any position) on the index date or during the pre-index period;
Patients must have a prescription for dabigatran or warfarin (this first prescription will be the index date);
Patients must be treatment naive from all OAC use prior to first dabigatran or warfarin prescription;
Aged 18-89 on the index date;
You may not be if
Patients with valvular procedures related to the baseline AF diagnosis will be excluded;
Patients with transient causes of AF such as hyperthyroidism, any cardiac surgery, pericarditis, mycoarditis, pulmonary embolism within 3 months prior to their first diagnosis of AF;
Clareo Health | The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage